Rancho Santa Fe Bio, Inc.
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Rancho Santa Fe Bio, Inc.
Roche gives back choroideremia candidate to 4D Molecular after reviewing Phase I data, partners on synthetic GI therapy with Synlogic. AbbVie opts to acquire TeneoOne under 2019 agreement.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.